# data[].attributes.body
Crohn’s disease (as well as inflammatory bowel disease) is notably a global issue that is costing the world hundreds of billions of dollars mostly due to the lack of programs and awareness. With industrial progressions and global awareness increasing, it is hopeful that with more research done on this issue, the lesser the costs (direct and indirect) will be associated as more effective therapies to induce and maintain remission become available to CD and IBD patients worldwide.

# data[].attributes.body
Of the Chinese population, there seems to be an increasing trend of Crohn’s disease in the Singapore Chinese population (Leong, 2004). Countries with the highest incidences of CD involve Turkey, Lebanon, and South Korea (Behzadi, P., Behzadi, E., and Panjbar, 2015). Lebanon, Japan, and South Korea rank as the first three countries with the highest prevalence. Also experiencing increasingly higher rates of CD in the last three decades are South Korea, Japan, and Hong Kong.

# data[].attributes.body
Approximately 2.5-3 million people suffer from Crohn’s disease in Europe with around 18,000 new cases per year (Burisch, Jess, Martinato, Lakatos, 2013). Within Europe, the highest incidence and prevalence rates are found in Scandinavia and the United Kingdom while the diseases remain rare in Eastern Europe (Burisch, 2014).

# data[].attributes.body
Incidence of inflammatory bowel disease has substantially increased, the severity of the disease has worsened, and people are being diagnosed at an earlier age in Australia.

# data[].attributes.body
Canada has among the highest reported incidence rates of inflammatory bowel disease in the world equating to more than 1 in every 150 Canadians according to the Crohn’s and Colitis Foundation of Canada (2012)

# data[].attributes.body
According to the Crohn’s and Colitis Foundation of America (2015), approximately 700,000 Americans have Crohn’s disease in the United States. Studies have estimated the annual direct cost of Crohn’s disease to be from $8,265 to $18,963 per patient.

# data[].attributes.body
Inflammatory Bowel Disease is a growing global problem where .5% of people in the Western world are now affected. Although there may a lack of programs and research available in developing countries, there is enough evidence to suggest that the rates of Crohn’s disease incidences, as well as its costs, are notably increasing all across the globe

# data[].attributes.body
Not only does CD appear to be more common among the Ashkenazi Jewish population, but people who live in higher altitudes are more likely to develop Crohn’s disease than those in lower altitudes (Behzadi, Behzadi, Ranjbar, 2015).

# data[].attributes.body
Definition, causes, symptoms, treatments

# data[].attributes.attachment_link.description
Produced by Thrive Creations, a video production company in Nashville. Thrive Creations specializes in live action, white board animation and hand drawn illustration videos. http://thrivecreations.com/